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Abstract
PURPOSE: This study examined the effects of a novel maltodextrin-fructose hydrogel (MF-H) on
cycling performance and gastrointestinal distress symptoms. METHODS: Nine endurance-trained
male cyclists completed three experimental trials consisting of a 98-min varied-intensity cycling
protocol followed by a performance test of ten consecutive sprint intervals. In a cross-over
design, subjects consumed 250 mL of a treatment beverage every 15 min of cycling. The
treatments consisted of 78 g . hr-1 of either a) MF-H, b) maltodextrin-fructose (MF), and c)
maltodextrin only (MD) All data were assessed using repeated measures ANOVA’s. RESULTS:
There were no differences in average sprint power between treatments (MF-H, 284 ± 51 W; MF,
281 ± 46 W; and MD, 277 ± 48 W), or power output for any individual sprint. However, mean
power output for sprints 7-10 was significantly lower in MD (259 ± 2 W) versus MF (269 ± 2 W;
p=0.04) and versus MF-H (270 ± 2 W; p=0.01). Subjective ratings of gastrointestinal discomfort
symptoms (nausea, fullness, and abdominal cramping) increased significantly over time during
the cycling trials, but few individuals exceeded moderate levels in any trial with no systematic
differences in gastrointestinal discomfort symptoms observed between treatments.
CONCLUSIONS: Ingestion of a maltodextrin/fructose hydrogel beverage improved cycling
performance late in exercise compared to maltodextrin alone, but provided no further
performance benefits versus a maltodextrin/fructose beverage.

In addition, the

maltodextrin/fructose hydrogel beverage resulted no systematic benefits in gastrointestinal
comfort versus the other beverages.
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Chapter One
Introduction
Carbohydrates and fats are the two primary sources of fuel utilized by the muscle during
endurance exercise, and their proportional utilization varies depending on the intensity and
duration of the activity (Romjin et al., 1993). During low and moderate intensity exercise, fat is
the predominant substrate oxidized, with carbohydrate utilization increasing as intensity is
increased (Loon et al., 2001, Romjin et al., 1993). Competitive endurance athletes have a high
reliance on carbohydrate during exercise, but have a somewhat limited carbohydrate reserve
from endogenous sources such as liver and muscle glycogen or blood glucose (Hermansen et al.,
1967). Decreased muscle/liver glycogen and blood glucose during prolonged duration exercise
leads to reduced carbohydrate oxidation rates, which may limit endurance performance during
activities of approximately 2 h or longer (Coyle et al., 1986). As such, carbohydrate ingestion,
typically in the form of carbohydrate-electrolyte beverages, has been utilized to sustain
carbohydrate oxidation rates, maintain higher ATP turnover, and augment performance.
Several studies have reported that carbohydrate ingestion during prolonged exercise has
positive effects on endurance performance. During exercise protocols 2 h, researchers have
reported that carbohydrate ingestion improves time to fatigue by an average of 24.8% versus
placebos, and time trial performance by 2-8 % (Stellingwerff & Cox 2014). Carbohydrate intake
during exercise has resulted in ergogenic effects with ingestion rates as low as 10 g/h, as Smith
et al. reported a 1% improvement in cycling performance compared to placebo (Smith et al.,
2013). However, most studies reporting improvements in performance with carbohydrate intake
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during exercise have utilized ingestion rates  30 g/hr (Jentjens et al., 2004). As such, published
guidelines from sports nutrition groups generally recommend consuming 30 to 60 g of
carbohydrate per hour of activity throughout prolonged endurance activities (Kreider et al.,
2010).
There is evidence that exogenous carbohydrate oxidation rates and performance gains
are elevated in dose-response fashion to the amount of glucose (or maltodextrin) ingested, up
to 60 g/h (Smith et al., 2010). It is believed that the upper-limit for this dose is limited by
gastrointestinal uptake of glucose, which is facilitated by the sodium-glucose linked transporter
1 (SGLT1) (Ferraris 2001). This transporter becomes saturated at ingestion rates of 1.0 – 1.1
g/min, preventing further uptake to the blood (and ultimately, delivery to the muscle for
oxidation) (Jeukendrup et al., 2000, Triplett et al., 2010). As a result, very high rates of glucose
ingestion (> 60 g/h or 1.1 g/min) do not result in further improvements in performance and are
also associated with increased gastrointestinal discomfort (Triplett et al., 2010).
Although the maximum effective dose of glucose is limited by SGLT1, fructose utilizes a
non-competitive sodium independent intestinal transporter (GLUT5), which is believed to be
saturated at ingestion rates of 0.5 - 0.6 g/min (Currell & Jeukendrup 2008, Shi et al., 1997). Recent
studies have reported that the combined ingestion of glucose (or maltodextrin) and fructose
results in higher peak exogenous carbohydrate oxidation rates than glucose alone (Jentjens &
Jeukendrup 2005; Jentjens et al., 2004a & 2004b). For example, in a review by Jeukendrup, it was
reported that exogenous oxidation rates were significantly higher (1.26 g/min) in response to
feedings of 1.8 g/min of glucose/fructose versus the same amount of glucose alone (0.80 g/min)
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(Jeukendrup 2008). The resulting increase in exogenous carbohydrate oxidation with multiple
transportable carbohydrates may be associated with sparing of endogenous carbohydrate
reserves, which could result in higher total carbohydrate availability late in exercise, thereby
improving performance (Jentjens & Jeukendrup 2005; Jentjens et al., 2004a & 2004b).
The use of multiple transportable forms of carbohydrate (glucose/maltodextrin and
fructose) can potentially improve performance more than glucose alone during moderate to high
intensity exercise (>2 h) by increasing exogenous carbohydrate oxidation (and possibly total
carbohydrate oxidation late in exercise) in glucose/fructose compared to glucose only trials. Two
studies have reported superior cycling performances (approximately 8%) when high doses of
glucose/fructose (108-144 g/h) were consumed, versus isocaloric glucose-only trials (Currell &
Jeukendrup 2008, Triplett et al., 2010).
Gastrointestinal distress from malabsorption of carbohydrates can interfere with
potential ergogenic effects from carbohydrate supplementation during prolonged exercise.
Nausea, vomiting, and other upper and lower GI tract issues have been reported extensively in
long distance athletes (Keeffe et al., 1984, Rehrer et al., 1989). Using multiple transportable
forms of carbohydrate may attenuate gastrointestinal distress due to having two noncompetitive transport mechanisms for carbohydrate absorption (Wilson 2015). This is supported
by Rowlands et al., who found improvements in performance with maltodextrin-fructose
beverages to be related to improvements in gastrointestinal discomfort (Rowlands et al., 2012).
Additionally, another factor which may influence gastrointestinal comfort is the rate of gastric
emptying, or the rate at which contents from the stomach enters the intestinal tract (Costill et
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al., 1970). Gastric emptying can be influenced by the concentration of carbohydrate, volume of
fluid, caloric content, and a variety of other factors discussed in previous literature (Murray
1987). In an attempt to provide carbohydrate doses that optimize oxidation rates (i.e. ~ 1 g/min
of GLU and ~ 0.5 g/min of FRUC) without gastrointestinal distress, Maurten sports drinks created
a product utilizing hydrogels in their formula (using pectin and alginate) to promote enhanced
gastric emptying. There are anecdotal reports that professional marathon runners have used this
product

successfully

since

2016

(https://www.maurten.com/achievements).

From

a

pharmacological standpoint, hydrogels have been used for drug delivery for site-specific release
(Ahmed 2015; Hamidi 2008). Polymers containing pendant acids (carboxylic acid) such as those
in pectin and alginate, change in accordance to their pH environment and other factors (Qiu &
Park 2001). Due to the pH differences between the stomach and the intestines, pH-dependent
polyelectrolyte hydrogels cause swelling of the mix in the stomach (< 3 pH), allowing controlled
gastric emptying into the intestines where the pH is more neutral (~ 6-7) (Qiu & Park 2001). With
oral administration, pH-sensitive carbohydrate hydrogels can theoretically control the release of
their contents and mitigate gastrointestinal distress by controlling the rate of gastric emptying,
while allowing for optimal absorption of carbohydrate from the intestines. Thus, carbohydrate
hydrogels could theoretically provide increased carbohydrate delivery and attenuate
gastrointestinal distress, potentially resulting in performance benefits during prolonged
moderate to high intensity exercise (>2 h). However, no peer-reviewed studies have been
completed to date on the effects of hydrogel use on carbohydrate delivery and endurance
performance.
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Therefore, the purpose of this study is to determine the effects of a Maurten hydrogel
solution containing 80g/h of maltodextrin and fructose (MF-H) on endurance performance and
gastrointestinal comfort compared to an isocaloric maltodextrin-fructose solution (MF) and an
isocaloric maltodextrin-only solution (MD), during a 98-min varied-load cycle test followed by a
sprint-interval performance test (Guillochon & Rowlands 2017). We predict that MF-H will result
in attenuated gastrointestinal distress versus MD and MF, and improved cycling performance
versus MD, with similar performance effects versus MF.
Assumptions, Limitations, Delimitations
Due to the abundance of evidence suggesting exogenous carbohydrate improves
performance through the mechanisms discussed previously, we are assuming MF-H, along with
our other carbohydrate derivations will provide an ergogenic effect versus water alone and are
therefore not including a placebo trial. We also assume that individuals will complete the tasks
to the best of their ability, so we may assess variations among interventions and not from
individual variations of performance effected by willingness, attentiveness, and other
motivational factors.
We are examining the effects of carbohydrate ingestion on trained cyclists. This limits our
generalizability to only trained individuals that are performing bouts of activity that are between
2 and 3 hours. With many studies looking at a carbohydrate intervention and exercise, our sample
size will be limited in terms of numbers due to the lack of well-trained endurance athletes willing
and able to participate to exhaustion in our study.
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Delimitations of this study include using cyclists to assess the ergogenic effects of the
aforementioned carbohydrate beverages. This limits our study to only being able to apply our
data that we find to trained cyclists that are performance 2 to 3-hour bouts of activity. To provide
sufficient controls for our study, we are standardizing the time of fasting and nutrient intake prior
to testing, as well as time of day to better understand the carbohydrates effect on prolonged
exercise.
Definition of Terms
There are several definitions that require clarification as they relate to the data outcomes
for the present study. First, fatigue is defined as the volitional withdrawal of the exercise
intervention or an individual’s inability to further perform the given task due to excessive
exhaustion. Gastrointestinal distress will be defined by assessing ratings of gut discomfort,
including the degree of sensations indicating likelihood of nausea, stomach fullness, or abdominal
cramping. We define trained cyclists as individuals completing  3 d/wk of cycling, and a VO2max
value  50 ml.kg-1.min.
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Chapter Two
Methods
Subjects
Eleven endurance-trained male cyclists were recruited from the areas of Harrisonburg,
VA and Elon, NC to participate in this study. Inclusion criteria were: males aged 18 to 45 years of
age, cycling  3 d . wk for three months prior to the study, with a VO2max  50 ml.kg-1.min, and
competing regularly ( 3 years of competitive cycling or training). Exclusion criterion for this study
were: smokers (current or former), failure to meet inclusion requirements, and intolerance to
testing procedures. Subjects were provided with information about study procedures and risks
and provided consent to participate prior to initiating the study. This study was approved by the
Institutional Review Boards of James Madison University and Elon University.
Research Design
The study was a randomized, double-blinded, crossover design to test the effects of three
carbohydrate beverages on performance, metabolic physiology, and gastrointestinal distress.
Trials were separated by 3-7 days with subjects receiving standardized diet and exercise
instructions. Trials were conducted at a consistent time of day to control variability within
subjects. Subjects underwent four trials 1) preliminary testing and familiarization trial, 2-4)
experimental trials with one of three carbohydrate interventions. Each trial consisted of a preloaded varied-intensity protocol of 98 min, followed immediately by a performance test to
determine power output during 10 consecutive sprints.
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Preliminary testing and familiarization trial
Before any experimental trials were conducted, participants underwent a graded exercise
test on a cycle ergometer (Velotron; RacerMate Inc., Seattle, WA) to determine maximal oxygen
consumption (VO2max) and maximal power output (Wmax) using a protocol described previously
(Triplett et al., 2010; Kreider et al., 2010). After a 10-min warm-up at 100 W, subjects began the
test at a pre-determined wattage based on body weight (W = 3*subject BW (kg)). Power output
was then increased by 25W every 2-min until volitional exhaustion. Metabolic responses during
each stage was recorded using a Parvo Medics TrueOne 2400 (Parvo Medics, Sandy, UT). VO2max
was determined by the highest 30 s mean oxygen uptake value. Following the VO2max trial,
subjects were given 5-min rest, followed by a familiarization with the last 60-min of the pre-load
protocol and the performance test.
Diet and exercise control
Subjects were instructed to 1) maintain consistent diet and training in the 72 h prior to each
performance trials, 2) engage in a 90-min moderate intensity ride 48 h prior to performance trial,
3) record food intake and physical activity for 24 h prior to first experimental trial, 4) repeat food
intake from recorded data in subsequent trials, 5) rest from exercise for 24 h leading to trial, and
6) refrain from consuming alcohol and caffeine for 24 h and 12 h, respectively, prior to trials (Fig
1). Subjects were all fed during performance trials as shown in Figure 2. Two hours prior to trials,
subjects consumed standard meals consisting of a Clif Energy Bar (Clif Bar & Company;
Emerysville, CA), and 300 mL of water.
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Figure 1. Seven-day Exercise Instructions Leading to Experimental Trials

Exercise trials
As shown in Figure 2, subjects completed a 98 min pre-load trial to simulate a cycling road
race using a cycle ergometer (Velotron; RacerMate Inc., Seattle, WA). This trial consisted of 60min of constant-load exercise at 50% Wmax followed by eight, 2-min intervals at 80% Wmax. Rest
intervals were performed at 50% of Wmax and lasted 2 min, except for a 5-min rest interval
between the the fourth and fifth work interval (Coggan & Coyle 1987). Following the 98-min
protocol, subjects performed a performance test consisting of ten sprints. Subjects were
instructed to give maximal efforts with each sprint and subsequent recovery until a
predetermined kilocalorie requirement was met, based on the subject’s wattage at max and body
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weight in kilograms (Wmax * 0.125). Sprints were designed to be approximately 2-3 min in length
with the rest period (40% Wmax) lasting approximately 5 min. During the sprints, subject’s power
output data was withheld to prevent pacing versus other trials. Power output, time to complete
sprints and rest periods were collected in addition to any physiological data and perceptual
responses collected throughout the study duration.
Figure 2. Overview of Exercise Trial and Measurements

Physiological measurements
Heart rate (Polar Electro Inc.; Bethpage, NY) was recorded every 15 min, and at test
termination (Fig. 2). Oxygen uptake (VO2) respiratory exchange ratio (RER) were assessed using
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a PARVO Metabolic System (PARVO Medics; Sandy, UT) at minutes 15-20, 45-50, and 93-98
during the pre-load phase, and at minutes 160-165 during the performance trial (Fig 2). Finger
stick blood samples (0.5 mL) were obtained at the following time intervals: prior to exercise, at
minutes 45, 98, and 160, and immediately following the performance test (Fig. 2). Lactate and
glucose levels were assessed from whole blood using automated instrumentation (YSI 2900D
Biochemistry analyzer YSI Life Sciences, Yellow Springs, OH).
Perceptual Responses and Gastrointestinal Distress Scale
Gastrointestinal distress symptoms and perceived exertion responses were indicated in
writing at every 15-min interval (fig. 2) using a 100-point scale (i.e. 1 = no GI distress; 100 =
absolute maximum) adapted from Jentjens et al. (2002). Subjects were instructed to draw a line
across the scale every time interval to indicate their symptoms. Subjects rated symptoms
including: nausea, fullness, and abdominal cramping, in addition to effort of cycling, tiredness,
and leg strength. A ruler with mm increments was used to measure ratings for each variable.
Treatments
Subjects received 250 mL of treatment beverage immediately prior to the exercise trials,
and 250 mL every 15-min of exercise. Participants consumed 78 g . hr-1 (1.3 g . min-1), and 1000
mL/hr fluid (7.8% concentration) or 3000 mL total over a 3 h period during all trials. Treatments
consisted of either a) Maltodextrin-fructose hydrogel (MF-H) (Maurten AB, Gothenburg,
Sweden), providing 78 g of carbohydrate (from maltodextrin and fructose), using Maurten’s
proprietary 160 mix (two sachets), b) maltodextrin-fructose (MF) beverage providing
maltodextrin and fructose (Tate and Lyle, Decatur, IL) in a 3:1 ratio with 78 g total carbohydrate,
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c) maltodextrin (MD) beverage providing 78 g of carbohydrate with maltodextrin only. Each
beverage was made using spring water (Deer Park Spring Water, Nestlé Waters North America),
and included 800 mg sodium (Morton salt; Chicago, IL) per liter, with the exception of the
Maurten beverage, which was mixed using manufacturer’s recommendations. Treatments were
randomized and double-blinded.
Statistical analysis
Statistical analyses were performed using Statistical Package for the Social Sciences
(SPSS). Mean values and standard deviations were calculated and reported for all dependent
measures discussed above. Treatment differences in these variables were assessed using
repeated measures ANOVA’s, with individual treatment comparisons performed with Fisher’s
least significant difference test (i.e. no correction for multiple comparisons).
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Chapter Three
Manuscript
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Effects of a Carbohydrate Hydrogel Beverage on Endurance Cycling Performance and
Gastrointestinal Comfort

Authors: Harrison R. Toney, Michael J. Saunders, Nicholas D. Luden,
Daniel A. Baur, Christopher J. Womack, Katherine G. Baur
Institution: James Madison University, Harrisonburg VA, 22807
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Abstract
PURPOSE: This study examined the effects of a novel maltodextrin-fructose hydrogel (MF-H) on
cycling performance and gastrointestinal distress symptoms. METHODS: Nine endurance-trained
male cyclists completed three experimental trials consisting of a 98-min varied-intensity cycling
protocol followed by a performance test of ten consecutive sprint intervals. In a cross-over
design, subjects consumed 250 mL of a treatment beverage every 15 min of cycling. The
treatments consisted of 78 g . hr-1 of either a) MF-H, b) maltodextrin-fructose (MF), and c)
maltodextrin only (MD) All data were assessed using repeated measures ANOVA’s. RESULTS:
There were no differences in average sprint power between treatments (MF-H, 284 ± 51 W; MF,
281 ± 46 W; and MD, 277 ± 48 W), or power output for any individual sprint. However, mean
power output for sprints 7-10 was significantly lower in MD (259 ± 2 W) versus MF (269 ± 2 W;
p=0.04) and versus MF-H (270 ± 2 W; p=0.01). Subjective ratings of gastrointestinal discomfort
symptoms (nausea, fullness, and abdominal cramping) increased significantly over time during
the cycling trials, but few individuals exceeded moderate levels in any trial with no systematic
differences in gastrointestinal discomfort symptoms observed between treatments.
CONCLUSIONS: Ingestion of a maltodextrin/fructose hydrogel beverage improved cycling
performance late in exercise compared to maltodextrin alone, but provided no further
performance benefits versus a maltodextrin/fructose beverage.

In addition, the

maltodextrin/fructose hydrogel beverage resulted no systematic benefits in gastrointestinal
comfort versus the other beverages.
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Introduction
Competitive endurance athletes utilize carbohydrate extensively during exercise, but
have limited endogenous carbohydrate reserves from liver/muscle glycogen and blood glucose
(Hermansen et al., 1967). Decreased muscle/liver glycogen and blood glucose during prolonged
exercise leads to reduced carbohydrate oxidation rates, which may limit endurance performance
during activities ~ 2 h or longer (Coyle et al., 1986). Importantly, the ingestion of carbohydrate
beverages during prolonged exercise has been shown to sustain carbohydrate oxidation rates,
maintain higher ATP turnover, and augment performance.
Numerous studies have reported that carbohydrate ingestion during prolonged exercise
has positive effects on performance.

Sports nutrition guidelines generally recommend

consuming 30 - 60 g/h of carbohydrate throughout prolonged endurance activities (Kreider et al.,
2010). However, there is evidence that exogenous carbohydrate oxidation rates and
performance gains are elevated in dose-response fashion to the amount of glucose/maltodextrin
ingested, up to 60 g/h (Smith et al., 2010). Carbohydrate intake beyond 60 g/h can lead to
gastrointestinal (GI) distress from malabsorption of carbohydrates, consequently interfering with
the potential ergogenic effects of carbohydrate supplementation. Indeed, nausea, vomiting, and
other upper and lower GI tract issues have been reported extensively in long distance athletes
(Keeffe et al., 1984, Rehrer et al., 1989). A novel strategy to optimize performance gains while
minimizing GI discomfort is the use of multiple transportable forms of carbohydrate which utilize
non-competitive transport mechanisms for carbohydrate absorption (Wilson 2015). The
ingestion of multiple carbohydrate types, which utilize non-competitive gastrointestinal (GI)
uptake receptors [i.e. glucose (SGT1) + fructose (GLUT5)] allows for higher ingestion rates during
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endurance exercise (Smith, 2013), resulting in greater ergogenic effects compared to ingestion
of just glucose alone (i.e. Currell & Jeukendrup, 2008; Tripplett et al., 2010).
In an attempt to maximize carbohydrate intake without GI distress, Maurten sports drinks
created a product utilizing hydrogels to enhance gastric emptying. Polymers containing pendant
acids (i.e. carboxylic acid, such as in pectin and alginate) change in accordance to their pH
environment and other factors (Qiu & Park 2001). Due to the pH differences between the
stomach and intestines, pH-dependent polyelectrolyte hydrogels reportedly cause swelling of the
mix in the stomach, allowing controlled gastric emptying into the intestines where the pH is more
neutral (Qiu & Park 2001). Anecdotal reports suggest that some professional marathon runners
have used this product successfully since 2016, and it has recently been marketed to competitive
cyclists (https://www.maurten.com/achievements). However, no peer-reviewed studies have
examined the effects of carbohydrate hydrogel ingestion on carbohydrate delivery and
endurance performance.
Therefore, the purpose of this study was to determine the effects of a Maurten hydrogel
solution containing 78 g/h of maltodextrin and fructose (MF-H) on endurance performance and
GI comfort compared to an isocaloric maltodextrin-fructose solution (MF) and an isocaloric
maltodextrin-only solution (MD), during a 98-min varied-load cycle test followed by a sprintinterval performance test (Guillochon & Rowlands 2017). We hypothesize that MF-H will result
in attenuated GI distress versus MD, but not MF, and improved cycling performance versus MD,
with similar performance effects versus MF.
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Methods
Subjects
Eleven endurance-trained male cyclists were recruited from the areas of Harrisonburg,
VA and Elon, NC to participate in this study. Inclusion criteria were: males aged 18 to 45 years of
age, cycling  3 d . wk for three months prior to the study, with a VO2max  50 ml.kg-1.min, and
competing regularly ( 3 years of competitive cycling or training). Exclusion criterion for this study
were: smokers (current or former), failure to meet inclusion requirements, and intolerance to
testing procedures. Subjects were provided with information about study procedures and risks
and provided consent to participate prior to initiating the study. This study was approved by the
Institutional Review Boards of James Madison University and Elon University.
Research Design
The study was a randomized, double-blinded, crossover design to test the effects of three
carbohydrate beverages on performance, metabolic physiology, and gastrointestinal distress.
Trials were separated by 3-7 days with subjects receiving standardized diet and exercise
instructions. Trials were conducted at a consistent time of day to control variability within
subjects. Subjects underwent four trials 1) preliminary testing and familiarization trial, 2-4)
experimental trials with one of three carbohydrate interventions. Each trial consisted of a preloaded varied-intensity protocol of 98 min, followed immediately by a performance test to
determine power output during 10 consecutive sprints.
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Preliminary testing and familiarization trial
Before any experimental trials were conducted, participants underwent a graded exercise
test on a cycle ergometer (Velotron; RacerMate Inc., Seattle, WA) to determine maximal oxygen
consumption (VO2max) and maximal power output (Wmax) using a protocol described previously
(Triplett et al., 2010; Kreider et al., 2010). After a 10-min warm-up at 100 W, subjects began the
test at a pre-determined wattage based on body weight [W = 3*subject BW (kg)]. Power output
was then increased by 25W every 2-min until volitional exhaustion. Metabolic responses during
each stage was recorded using a Parvo Medics TrueOne 2400 (Parvo Medics, Sandy, UT). VO2max
was determined by the highest 30 s mean oxygen uptake value. Following the VO2max trial,
subjects were given 5-min rest, followed by a familiarization with the last 60-min of the pre-load
protocol and the performance test.
Diet and exercise control
Subjects were instructed to 1) maintain consistent diet and training in the 72 h prior to
each performance trials, 2) engage in a 90-min moderate intensity ride 48 h prior to performance
trial, 3) record food intake and physical activity for 24 h prior to first experimental trial, 4) repeat
food intake from recorded data in subsequent trials, 5) rest from exercise for 24 h leading to trial,
and 6) refrain from consuming alcohol and caffeine for 24 h and 12 h, respectively, prior to trials
(Fig 1). Subjects were all fed during performance trials as shown in Figure 2. Two hours prior to
trials, subjects consumed standard meals consisting of a Clif Energy Bar (Clif Bar & Company;
Emerysville, CA), and 300 mL of water.
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Figure 1. Seven-day Exercise Instructions Leading to Experimental Trials

Exercise trials
As shown in Figure 2, subjects completed a 98 min pre-load trial to simulate a cycling road
race using a cycle ergometer (Velotron; RacerMate Inc., Seattle, WA). This trial consisted of 60min of constant-load exercise at 50% Wmax followed by eight, 2-min intervals at 80% Wmax. Rest
intervals were performed at 50% of Wmax and lasted 2 min, except for a 5-min rest interval
between the fourth and fifth work interval (Coggan & Coyle 1987). Following the 98-min protocol,
subjects performed a performance test consisting of ten sprints. Subjects were instructed to give
maximal efforts with each sprint and subsequent recovery until a predetermined kilocalorie
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requirement was met, based on the subject’s wattage at max and body weight in kilograms (Wmax
* 0.125). Sprints were designed to be approximately 2-3 min in length with the rest period (40%
Wmax) lasting approximately 5 min. During the sprints, subject’s power output data was withheld
to prevent pacing versus other trials. Power output, time to complete sprints and rest periods
were collected in addition to any physiological data and perceptual responses collected
throughout the study duration.
Figure 2. Overview of Exercise Trial and Measurements
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Physiological measurements
Heart rate (Polar Electro Inc.; Bethpage, NY) was recorded every 15 min, and at test
termination (Fig. 2). Oxygen uptake (VO2) respiratory exchange ratio (RER) were assessed using
a PARVO Metabolic System (PARVO Medics; Sandy, UT) at minutes 15-20, 45-50, and 93-98
during the pre-load phase, and at minutes 160-165 during the performance trial (Fig 2). Finger
stick blood samples (0.5 mL) were obtained at the following time intervals: prior to exercise, at
minutes 45, 98, and 160, and immediately following the performance test (Fig. 2). Lactate and
glucose levels were assessed from whole blood using automated instrumentation (YSI 2900D
Biochemistry analyzer YSI Life Sciences, Yellow Springs, OH).
Perceptual Responses and Gastrointestinal Distress Scale
Gastrointestinal distress symptoms and perceived exertion responses were indicated in
writing at every 15-min interval (fig. 2) using a 100-point scale (i.e. 1 = no GI distress; 100 =
absolute maximum) adapted from Jentjens et al. (2002). Subjects were instructed to draw a line
across the scale every time interval to indicate their symptoms. Subjects rated symptoms
including: nausea, fullness, and abdominal cramping, in addition to effort of cycling, tiredness,
and leg strength. A ruler with mm increments was used to measure ratings for each variable.
Treatments
Subjects received 250 mL of treatment beverage immediately prior to the exercise trials,
and 250 mL every 15-min of exercise. Participants consumed 78 g . hr-1 (1.3 g . min-1), and 1000
mL/hr fluid (7.8% concentration) or 3000 mL total over a 3 h period during all trials. Treatments
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consisted of either a) Maltodextrin-fructose hydrogel (MF-H) (Maurten AB, Gothenburg,
Sweden), providing 78 g of carbohydrate (from maltodextrin and fructose), using Maurten’s
proprietary 160 mix (two sachets), b) maltodextrin-fructose (MF) beverage providing
maltodextrin and fructose (Tate and Lyle, Decatur, IL) in a 3:1 ratio with 78 g total carbohydrate,
c) maltodextrin (MD) beverage providing 78 g of carbohydrate with maltodextrin only. Each
beverage was made using spring water (Deer Park Spring Water, Nestlé Waters North America),
and included 800 mg sodium (Morton salt; Chicago, IL) per liter, with the exception of the
Maurten beverage, which was mixed using manufacturer’s recommendations. Treatments were
double-blinded and provided in a randomly-counterbalanced order.
Statistical analysis
Statistical analyses were performed using Statistical Package for the Social Sciences
(SPSS). Mean values and standard deviations were calculated and reported for all dependent
measures discussed above. Treatment differences in these variables were assessed using
repeated measures ANOVA’s, with individual treatment comparisons performed with Fisher’s
least significant difference test (i.e. no correction for multiple comparisons).
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Results
Demographics
Eleven trained male cyclists (VO2max ≥ 50 ml.kg-1.min) from James Madison University and
Elon University enrolled in this study. Nine of the eleven subjects completed the study, as one
withdrew due to an injury unrelated to the study, and another failed to complete an experimental
trial. Subject demographics are displayed in Table 1.
Table 1. Descriptive data of subjects (n=9); Mean ± SD
Age
26.1 ± 6.6

Weight (kg)
80.9 ± 10.4

Peak VO2 (mL.kg-1.min)
55.5 ± 3.6

Peak Power (W)
356 ± 39

Years Racing
4.8 ± 3.2

Physiological Responses
Physiological responses during the cycling trials (VO2, RER, heart rate, blood glucose, and
blood lactate) are displayed in Table 2. During the pre-load trials, VO2 was higher in the MF-H
treatment than MD at 15-min (p=0.025). There were no other treatment differences observed
during the pre-load trials. During the sprint-interval trials, blood glucose was higher in the MF
trial versus MD (p=0.044), with no other treatment difference in physiological responses. Data
for lactate and glucose are reported for only eight subjects due to instrumentation errors during
the exercise trials.
Subjective Ratings
Subjective rating scores (mean ± SD) for effort, tiredness and leg strength during cycling
are displayed in Table 3. Ratings of effort and tiredness were generally ≤ 50mm (less than a
‘moderate’ rating) during the pre-load trials. Ratings of effort increased significantly over time
during the trials (p < 0.05), with the highest values during the sprint interval segment of the trials
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Table 2. Physiological Responses During the Cycling Protocol
Variable
VO2
(mL.min-1)

RER

Heart Rate
(bpm)

Glucose
(mg/dL)
Lactate
(mmol/L)

Treatment

Mean ± SD

MF

15-min
2476 ± 225

45-min
2486 ± 204

90-min
2725 ± 213

Sprint-7
2325 ± 262

MF-H

2528 ± 191*

2622 ± 204

2740 ± 226

2302 ± 281

MD

2392 ± 232

2457 ± 248

2677 ± 270

2269 ± 158

MF

0.92 ± 0.07

0.93 ± 0.08

0.92 ± 0.06

0.91 ± 0.06

MF-H

0.93 ± 0.05

0.93 ± 0.06

0.94 ± 0.06

0.91 ± 0.05

MD

0.92 ± 0.07

0.92 ± 0.07

0.92 ± 0.06

0.91 ± 0.07

MF

131 ± 8

132 ± 6

145 ± 11

166 ± 7

MF-H

132 ± 10

134 ± 11

145 ± 11

166 ± 6

MD

131 ± 10

133 ± 9

145 ± 13

167 ± 8

MF

77.6 ± 7.9

86.7 ± 8.3

80.8 ± 10.4

87.5 ± 12.9*

MF-H

74.7 ± 13.3

87.4 ± 10.9

85.2 ± 11.4

88.9 ± 12.6

MD

76.1 ± 8.9

88.5 ± 14.3

84.9 ± 14.0

81.9 ± 8.6

MF

0.97 ± 0.39

0.91 ± 0.37

2.76 ± 2.52

3.36 ± 3.14

MF-H

0.98 ± 0.39

1.02 ± 0.31

3.01 ± 2.30

3.26 ± 2.44

MD

1.04 ± 0.38

1.78 ± 2.85

2.84 ± 2.06

3.42 ± 2.55

Data are displayed as mean ± SD.
MF (maltodextrin + fructose) 1.33 g.min-1; MF-H (maltodextrin + fructose hydrogel) 1.33 g.min-1 ;
MD (maltodextrin-only) 1.33 g.min-1
*Denotes significant difference in comparison to MD

(≥ 67mm in all trials; ‘strong’ to ‘very strong’). There were no significant treatment-effects or
treatment x time interactions for effort ratings. Similarly, tiredness ratings increased to ≥ 67mm
(‘strong’ to ‘very strong’) across all trials with no systematic differences between treatments.
Perceived leg strength was ≥ 67 mm (‘strong’ or greater) during the pre-load trials, and ≤ 50 mm
(‘moderate’ to ‘weak or mild’) during the performance trial. No significant differences between
treatments were observed for tiredness or leg strength, though all ratings increased significantly
over time.
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Table 3. Subjective Ratings of Effort, Tiredness, and Leg Strength During Cycling
Variable

Effort of
Cycling
(0-100 mm)

Tiredness
(0-100 mm)

Leg Strength
(0-100 mm)

Treatment

Mean ± SD
15-min

45-min

90-min

Sprint-7

MF

29.9 ± 21.9

34.2 ± 19.2

53.7 ± 17.2

75.1 ± 14.6

MF-H

26.5 ± 13.9

34.9 ± 16.9

52.3 ± 15.3

72.2 ± 15.2

MD

20.3 ± 15.3

29.8 ± 16.3

46.3 ± 11.6

75.6 ± 13.1

MF

19.3 ± 14.4

29.8 ± 16.2

51.5 ± 18.7

72.6 ± 11.5

MF-H

14.9 ± 9.4

27.4 ± 15.4

49.4 ± 14.6

70.4 ± 9.7

MD

16.5 ± 13.8

27.5 ± 13.7

46.9 ± 12.5

70.6 ± 14.3

MF

79.4 ± 11.1

74.3 ± 10.5

58.1 ± 15.4

35.9 ± 14.8

MF-H

81.4 ± 9.4

75.1 ± 8.2

60.8 ± 11.3

43.3 ± 12.3

MD

83.2 ± 10.5

77.1 ± 7.6

58.6 ± 6.6

36.4 ± 9.9

Data are represented as mean ± SD. MF (maltodextrin + fructose) 1.33
fructose hydrogel) 1.33 g.min-1 ; MD (maltodextrin-only) 1.33 g.min-1

g.min-1;

MF-H (maltodextrin +

Gastrointestinal distress symptoms
GI symptoms (nausea, fullness, and abdominal cramping) are shown in Figures 3-5,
respectively. In general, GI symptoms increased over time (p < 0.05 for all symptoms). Symptoms
increased from ‘extremely weak’ (≤ 10 mm) at the onset of exercise to ‘weak or mild’ (≤ 30 mm)
by the end of the pre-load trials. Despite further increases in symptoms during the sprint
intervals, average values did not surpass ‘moderate’ ratings of discomfort. Individual responses
resulted in varied degrees of GI distress, and individual GI distress symptoms exceeding moderate
(≥ 50) and severe discomfort (≥ 65) are shown for each treatment in Table 4.
No significant treatment x time interactions were observed for any GI symptoms.
However, nausea ratings at 45 min were higher in MF-H versus MF (p=0.016). Stomach fullness
ratings at 30 min were higher in MF-H compared to MD (p=0.046) and MF (p=0.005), and stomach
fullness at 60 min was higher in MF-H versus MF (p=0.002) and at 75-min versus MD (p=0.037).
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Figure 3. Effect of CHO beverages on nausea ratings across all time points
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Data are displayed as mean ± SE. Significant main-effect for time (p < 0.05). MF (maltodextrin +
fructose) 1.33 g.min-1; MF-H (maltodextrin + fructose hydrogel) 1.33 g.min-1 ; MD (maltodextrin-only)
1.33 g.min-1. *p < 0.05; MF vs. MF-H.
Figure 4. Effect of CHO beverages on fullness ratings across all time points
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Data are displayed as mean ± SE. Significant main-effect for time (p < 0.05). MF (maltodextrin +
fructose) 1.33 g.min-1; MF-H (maltodextrin + fructose hydrogel) 1.33 g.min-1 ; MD (maltodextrin-only)
1.33 g.min-1. * p < 0.05; MF vs. MF-H; ^ p < 0.05; MF-H vs. MD.
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Figure 5. Effect of CHO beverages on abdominal cramping ratings across all time points

40

MF

MF-H

MD

Abdominal Cramping (mm)

35
30
25
20
15
10
5
0
15

30

45

60

75

Time

90

Spr-1 Spr-4 Spr-7

End

Data are displayed as mean ± SE. Significant main-effect for time (p < 0.05). MF (maltodextrin +
fructose) 1.33 g.min-1; MF-H (maltodextrin + fructose hydrogel) 1.33 g.min-1 ; MD (maltodextrin-only)
1.33 g.min-1.

Table 4. GI distress symptom incidences of moderate (m; ≥ 50) and severe discomfort (S; ≥ 65).
Nausea

15-min

MF
MF-H
MD
Fullness
MF
MF-H
MD
Abdominal cramping
MF
MF-H
MD

30-min

45-min

60-min

75-min

90-min

SPR1

SPR4

SPR7

END

1m

1m
1m
1m

1s
2m/1s
2m/1s

1s
1s
1m/2s

1s
2s
3s

1m

1m

1s

1m
2m
1m

1m
2m/1s
2m

1m/1s
3m/1s
1m/2s

1m/1s
2m/2s
1m/2s

1m

1m

1m

1s

1m/1s
1m
1m

1m
1m/1s
1m

1m
1m/1s

MF (maltodextrin + fructose) 1.33 g.min-1; MF-H (maltodextrin + fructose hydrogel) 1.33
g.min-1 ; MD (maltodextrin-only) 1.33 g.min-1.

29

Performance
Average power output over the 10 sprint intervals was not significantly different
between MF (281 ± 46 W), MF-H (284 ± 51 W) and MD (277 ± 48 W). In addition, average
power output during recovery periods between sprints was the same between MF (140 ± 13
W), MF-H (139 ± 14 W), and MD (139 ± 13 W). Sprint power output during individual sprint
intervals is illustrated in Figure 6. There were no significant between-treatment differences in
power output any individual sprint. However, there was a visual trend suggesting a tendency
for power output to be lower in the MD trial during the latter stages of the sprint trial, and
power output averaged over sprints 7-10 was significantly lower in MD (259 ± 2 W) versus MF
(269 ± 2 W; p=.044), and versus MF-H (270 ± 2 W; p=0.01).
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Figure 6. Power Output during Sprint Intervals for Each Treatment
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MF (maltodextrin + fructose) 1.33 g.min-1; MF-H (maltodextrin + fructose hydrogel) 1.33 g.min-1; MD
(maltodextrin-only) 1.33 g.min-1. * = significant difference between MF-H/MF versus MD.
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Discussion
The primary goal of this study was to determine the effects of a MF-H beverage on
endurance cycling performance and GI comfort ratings compared to MF and MD beverages,
matched for carbohydrate/caloric content. To our knowledge, this is the first study examining
the effects of carbohydrate hydrogels on these outcomes. Although ingestion of MF-H had no
significant effects on average power output over the entire sprint interval test, both MF-H and
MF provided greater sprint power over the final four sprints of the performance trial compared
to MD. No differences in performance were observed between MF-H and MF beverages. GI
distress symptoms increased throughout the duration of each trial, but there were no
systematically different ratings of GI symptoms between treatments, particularly late in exercise.
We observed no differential effects of the beverages on average sprint performance in
the present study (differences between MF-H/MF versus MD were 1.4/2.5%, respectively; N.S.).
However, power output averaged over the final four sprints was ~ 4% higher (p < 0.05) in the
beverages containing a mix of maltodextrin and fructose (MF-H and MF) versus maltodextrin
alone. This observation is generally consistent with prior studies examining the effects of
multiple transportable carbohydrate beverages (i.e. glucose/maltodextrin + fructose) on
performance. For example, Currell and Jeukendrup (2008) examined endurance performance
during a one-hour time trial that immediately followed 2 h of constant-load cycling, and reported
that average power output was 8.1% higher when subjects consumed glucose+fructose versus
an isocaloric amount of glucose alone. Similarly, Tripplett et al. (2010) found that average power
output during a 100 km time trial was 7.1 % higher when subjects ingested glucose+fructose
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versus an isocaloric glucose-only beverage. The large ergogenic effects reported in these studies
may have been due to substantially higher carbohydrate ingestion rates (108 – 144 g/h) than the
present study (78 g/h), which could have magnified the potential effects of glucose+fructose on
exogenous carbohydrate oxidation (discussed below), or exacerbated ergolytic effects of
excessive glucose in the glucose-only trials. In support of this concept, Baur and colleagues
(2014) reported that maltodextrin+fructose ingestion improved cycling time-trial performance
by 3.0 % compared to an isocaloric maltodextrin-only beverage (93 g/h); this effect was reduced
to 1.2 % when compared to a lower rate of maltodextrin intake (60 g/h). Similarly, Rowlands et
al (2012) found only modest improvements in cycling time-trial performance (1.8 %) and average
sprint power (1.4%) when comparing maltodextrin+fructose versus maltodextrin/glucose
beverages, when consumed at intake rates similar to the present study (~ 80 g/h). Therefore,
our findings support the existing literature, suggesting that the consumption of multiple
transportable carbohydrates provides modest ergogenic effects in comparison to single
carbohydrate sources.

However, our primary purpose was to determine if carbohydrate

hydrogels influence performance versus conventional carbohydrate beverages.

Although

ingestion of MF-H improved late-exercise performance compared to MD, MF-H did not provide
further benefits in comparison to MF. Our findings suggest that carbohydrate hydrogels do not
affect cycling performance to a greater extent than conventional beverages with the same
carbohydrate composition.
It is generally believed that the ergogenic effects of multiple transportable carbohydrates
are due to influences on a) total carbohydrate oxidation, and/or b) gastrointestinal comfort.
Maximal rates of carbohydrate oxidation with the consumption of glucose shows an upper limit
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of 60 g . hr-1 or 1 g . min-1 (Jeukendrup and Jentjens 2000). Ingestion of higher rates of a single
form of carbohydrate does not increase exogenous oxidation and is likely to be associated with
increased incidences of GI distress. This is because the intestines absorb glucose/maltodextrin
via the sodium-dependent glucose transporter 1 (SGT1) at a maximal rate ~1.0 to 1.1 g . min-1
(Jeukendrup et al., 2000). However, intestinal uptake of fructose occurs via the sodiumindependent transporter (GLUT5) which is a non-competitive uptake pathway to that of glucose
(Shi et al., 1997), at a rate of ~0.6 g . min-1 (Jeukendrup et al., 2004). Combining multiple
transportable carbohydrates has been reported to increase total carbohydrate oxidation rates
compared to single carbohydrate sources (Jentjens et al., 2004). The increase in exogenous
carbohydrate oxidation is generally believed to be beneficial due to a decreased reliance on
endogenous carbohydrate sources – mainly from the sparing of hepatic glycogen (Jentjens &
Jeukendrup 2005; Wallis et al., 2005). This could result in higher total carbohydrate oxidation
rates (exogenous + endogenous), supporting higher power output in the latter stages of
prolonged exercise. However, most metabolic responses between trials in this study were similar
between all treatments. It is worth noting that blood glucose levels during the sprint-intervals
was higher in the MF/MF-H trials (88/89 mg/dL) versus MD (82 mg/dL) providing some evidence
that carbohydrate availability may have been augmented in the MF/MF-H trials. However, we
observed no differences in RER (indicative of carbohydrate/fat utilization) between treatments
at any timepoint in the study. In addition, there were no differences in blood lactate values,
which could augment carbohydrate oxidation late in exercise (Lecoultre et al., 2010; Jentjens et
al., 2004). The lack of compelling evidence for elevated carbohydrate oxidation rates is in line
with prior studies reporting ergogenic effects with multiple transportable carbohydrates versus
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glucose/maltodextrin (i.e. Baur et al., 2014; Currell and Jeukendrup, 2008; Rowlands et al., 2012;
Tripplett et al, 2010), thereby necessitating more data to confirm the mechanisms for superior
performance.
The ergogenic effects of glucose/maltodextrin + fructose could also be related to
influences on GI tolerance (Baur et al., 2014; Rowlands et al., 2012). As discussed previously,
excessive glucose ingestion rates (and the associated effects on GI intolerance) could potentially
explain large performance effects reported for glucose + fructose beverages in some studies
(Currell and Jeukendrup, 2008; Tripplett et al., 2010). However, similar to Baur et al. (2014), we
observed no systematic reduction in GI discomfort symptoms during cycling with MF versus MD,
so we cannot directly associate the observed improvements in late-exercise power output with
influences on GI comfort. In addition, contrary to anecdotal reports, we observed no positive
effects of MF-H on GI distress symptoms such as nausea, fullness and abdominal cramping. In
fact, some measures of GI discomfort were higher in MF-H than other beverages during the preload trials (i.e. nausea ratings at 45-min, fullness ratings at 30, 60 & 75 min). However, we
conclude that any negative effects of MF-H on GI discomfort were trivial, as discomfort ratings at
these times were low (below ‘moderate’) and treatment differences did not persist into the later
stages of exercise, where discomfort ratings were higher and more likely to affect performance.
Therefore, we observed no systematic effects of MF or MF-H on GI discomfort. However, it is
worth noting that GI discomfort is influenced by a variety of exercise factors, such as intensity,
duration, mode of exercise, and environmental conditions (Rehrer et al., 1994). In the present
study (cycling exercise in a controlled environment at room temperature), the mean ratings for
all GI distress symptoms were < 50 (‘moderate’), suggesting that GI discomfort had a minimal
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influence on performance for most individuals under these conditions. Very few individuals
reported any ‘severe’ symptoms (≥ 65) at any time-point, but it could be instructive that the
highest number of severe symptoms were reported in the MD trial (3 for nausea; versus 2/1 for
MF-H/MF respectively). Therefore, it could be useful to further examine the effects of MF and
MF-H on GI discomfort under exercise conditions that elicit more severe GI distress symptoms.
The present study utilized trained cyclists as subjects to determine the efficacy of a
carbohydrate hydrogel on improvements in performance and GI distress during prolonged
exercise. Our study design utilized a sprint interval protocol in order to examine the effects of
carbohydrates on performance, and better replicate high-intensity efforts experienced during
cycling competitions. Additionally, GI distress is more commonly associated with high intensity
exercise, as illustrated by higher ratings of GI symptoms during the sprint interval segment of the
test. Though there were no observed benefits of MF-H over MF, future studies should consider
the influences of exercise modality and carbohydrate doses to determine whether MF-H
influences endurance performance and GI distress under different conditions. Larger sample
sizes would also provide greater statistical power to assess potentially small effects of
carbohydrate hydrogels on endurance performance.
In conclusion, we observed that carbohydrate beverages with maltodextrin + fructose
(MF and MF-H) improved late-exercise sprint performance versus MD alone. However, MF-H
provided no further benefits on performance versus MF. In addition, MF-H had no positive
effects on GI symptoms versus MF or MD. Therefore, our findings refute anecdotal reports that
MF-H beverages reduce GI discomfort and improve endurance performance. It remains to be
seen if carbohydrate hydrogels influence exercise performance or GI comfort when consumed:
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a) at higher dosages (≥ 1.3 g . min-1), or b) during exercise conditions that elicit more severe levels
of GI distress.

37

References
1. Ahmed, E. M. (2015). Hydrogel: Preparation, characterization, and applications: A review.
Journal of advanced research, 6(2), 105-121.
2. Baur, D. A., Schroer, A. B., Luden, N. D., Womack, C. J., Smyth, S. A., & Saunders, M. J. (2014).
Glucose-fructose enhances performance versus isocaloric, but not moderate, glucose. Med.
Sci. Sports Exerc, 46(9), 1778-1786.
3. Coggan, A. R., & Coyle, E. F. (1987). Reversal of fatigue during prolonged exercise by
carbohydrate infusion or ingestion. Journal of Applied Physiology, 63(6), 2388-2395.
4. Costill, D. L., Kammer, W. F., & Fisher, A. (1970). Fluid ingestion during distance running.
Archives of Environmental Health: An International Journal, 21(4), 520-525.
5. Coyle E, Coggan A, Hemert M, et al. Muscle glycogen utilization during prolonged strenuous
exercise when fed carbohydrate. J Appl Physiol. 1986;61(1):165–72.
6. Currell, K., & Jeukendrup, A. (2008). Superior endurance performance with ingestion of
multiple transportable carbohydrates. Medicine+ Science in Sports+ Exercise, 40(2), 275.
7. Ferraris, R. P. (2001). Dietary and developmental regulation of intestinal sugar transport.
Biochemical Journal, 360(2), 265-276.
8. Guillochon, M., & Rowlands, D. S. (2017). Solid, gel, and liquid carbohydrate format effects
on gut comfort and performance. International journal of sport nutrition and exercise
metabolism, 27(3), 247-254.
9. Hamidi, M., Azadi, A., & Rafiei, P. (2008). Hydrogel nanoparticles in drug delivery. Advanced
drug delivery reviews, 60(15), 1638-1649.

38

10. Hermansen, L., Hultman, E., & Saltin, B. (1967). Muscle glycogen during prolonged severe
exercise. Acta Physiologica, 71(2‐3), 129-139.
11. Jentjens, R. L., & Jeukendrup, A. E. (2005). High rates of exogenous carbohydrate oxidation
from a mixture of glucose and fructose ingested during prolonged cycling exercise. British
Journal of Nutrition, 93(4), 485-492.
12. Jentjens, R. L., Achten, J., & Jeukendrup, A. E. (2004). High oxidation rates from combined
carbohydrates ingested during exercise. Medicine and science in sports and exercise, 36(9),
1551-1558.
13. Jentjens, R. L., Moseley, L., Waring, R. H., Harding, L. K., & Jeukendrup, A. E. (2004).
Oxidation of combined ingestion of glucose and fructose during exercise. Journal of Applied
Physiology, 96(4), 1277-1284.
14. Jentjens, R. L., Moseley, L., Waring, R. H., Harding, L. K., & Jeukendrup, A. E. (2004). Oxidation
of combined ingestion of glucose and fructose during exercise. Journal of Applied Physiology.
15. Jentjens, R. L., Wagenmakers, A. J., & Jeukendrup, A. E. (2002). Heat stress increases muscle
glycogen use but reduces the oxidation of ingested carbohydrates during exercise. Journal
of applied physiology, 92(4), 1562-1572.
16. Jeukendrup, A. E. (2008). Carbohydrate feeding during exercise. European Journal of Sport
Science, 8(2), 77-86.
17. Jeukendrup, A. E., & Jentjens, R. (2000). Oxidation of carbohydrate feedings during prolonged
exercise. Sports Medicine, 29(6), 407-424.50.
18. Jeukendrup, A. E., Wagenmakers, A. J., Stegen, J. H., Gijsen, A. P., Brouns, F., & Saris, W. H.
(1999). Carbohydrate ingestion can completely suppress endogenous glucose production

39

during exercise. American Journal of Physiology-Endocrinology And Metabolism, 276(4),
E672-E683.
19. Keeffe, E. B., Lowe, D. K., Goss, J. R., & Wayne, R. (1984). Gastrointestinal symptoms of
marathon runners. Western Journal of Medicine, 141(4), 481.
20. Kreider, R. B., Wilborn, C. D., Taylor, L., Campbell, B., Almada, A. L., Collins, R., ... & Kerksick,
C. M. (2010). ISSN exercise & sport nutrition review: research & recommendations. Journal
of the international society of sports nutrition, 7(1), 7.
21. Lecoultre, V., Benoit, R., Carrel, G., Schutz, Y., Millet, G. P., Tappy, L., & Schneiter, P. (2010).
Fructose and glucose co-ingestion during prolonged exercise increases lactate and glucose
fluxes and oxidation compared with an equimolar intake of glucose. The American journal of
clinical nutrition, 92(5), 1071-1079.
22. Loon, L. J., Greenhaff, P. L., Constantin‐Teodosiu, D., Saris, W. H., & Wagenmakers, A. J.
(2001). The effects of increasing exercise intensity on muscle fuel utilisation in humans. The
Journal of physiology, 536(1), 295-304.
23. Murray, R. (1987). The effects of consuming carbohydrate-electrolyte beverages on gastric
emptying and fluid absorption during and following exercise. Sports Medicine, 4(5), 322-351.
24. Qiu, Y., & Park, K. (2001). Environment-sensitive hydrogels for drug delivery. Advanced drug
delivery reviews, 53(3), 321-339.
25. Rehrer, N. J., Janssen, G. M. E., Brouns, F., & Sa, W. H. M. (1989). Fluid Intake and
Gastrointestinal Problems in Runners Competingin a 25-km Race and a Marathon. Int. J.
Sports Med, 10, S22-S25.

40

26. Romijn, J. A., Coyle, E. F., Sidossis, L. S., Gastaldelli, A., Horowitz, J. F., Endert, E., & Wolfe, R.
R. (1993). Regulation of endogenous fat and carbohydrate metabolism in relation to exercise
intensity and duration. American Journal of Physiology-Endocrinology And Metabolism,
265(3), E380-E391.
27. Rowlands, D. S., Swift, M., Ros, M., & Green, J. G. (2012). Composite versus single
transportable carbohydrate solution enhances race and laboratory cycling performance.
Applied Physiology, Nutrition, and Metabolism, 37(3), 425-436.
28. Shi, X. I. A. O. C. A. I., Schedl, H. P., Summers, R. M., Lambert, G. P., Chang, R. T., Xia, T. I. N.
G., & Gisolfi, C. V. (1997). Fructose transport mechanisms in humans. Gastroenterology,
113(4), 1171-1179.
29. Smith, J. W., Pascoe, D. D., Passe, D. H., Ruby, B. C., Stewart, L. K., Baker, L. B., & Zachwieja, J.
J. (2013). Curvilinear dose–response relationship of carbohydrate (0–120 g· h− 1) and
performance. Medicine & Science in Sports & Exercise, 45(2), 336-341.
30. Smith, J. W., Zachwieja, J. J., Péronnet, F., Passe, D. H., Massicotte, D., Lavoie, C., & Pascoe,
D. D. (2010). Fuel selection and cycling endurance performance with ingestion of 13c-glucose:
evidence for a carbohydrate dose-response. journal of applied physiology.49.
31. Stellingwerff, T., & Cox, G. R. (2014). Systematic review: Carbohydrate supplementation on
exercise performance or capacity of varying durations. Applied Physiology, Nutrition, and
Metabolism, 39(9), 998-1011.
32. Triplett, D., Doyle, J. A., Rupp, J. C., & Benardot, D. (2010). An isocaloric glucose-fructose
beverage’s effect on simulated 100-km cycling performance compared with a glucose-only
beverage. International journal of sport nutrition and exercise metabolism, 20(2), 122-131.

41

33. Wagenmakers, A. J., Brouns, F. R. E. D., Saris, W. H., & Halliday, D. A. V. I. D. (1993).
Oxidation rates of orally ingested carbohydrates during prolonged exercise in men. Journal
of Applied Physiology, 75(6), 2774-2780.
34. Wallis, G. A., Rowlands, D. S., Shaw, C. H. R. I. S. T. O. P. H. E. R., Jentjens, R. L., &
Jeukendrup, A. E. (2005). Oxidation of combined ingestion of maltodextrins and fructose
during exercise. Medicine and Science in Sports and Exercise, 37(3), 426-432.
35. Wilson P, Ingraham S. Glucose-fructose likely improves gastrointestinal comfort and
endurance running performance relative to glucose-only. Scandinavian Journal Of Medicine
& Science In Sports [serial online]. December 2015;25(6):e613-e620. Available from:
SPORTDiscus with Full Text, Ipswich, MA.

